vs
Acadia Healthcare Company, Inc.（ACHC）とFabrinet（FN）の財務データ比較。上の社名をクリックして会社を切り替えられます
Fabrinetの直近四半期売上が大きい（$1.1B vs $821.5M、Acadia Healthcare Company, Inc.の約1.4倍）。Fabrinetの純利益率が高く（9.9% vs -143.3%、差は153.3%）。Fabrinetの前年同期比売上増加率が高い（35.9% vs 6.1%）。Fabrinetの直近四半期フリーキャッシュフローが多い（$-5.3M vs $-179.5M）。過去8四半期でFabrinetの売上複合成長率が高い（24.4% vs 3.4%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
Fabrinet（証券コード：FN）はS&Pミッドキャップ400指数の構成銘柄です。同指数はS&Pダウジョーンズインデックスが管理し、主に米国の中型企業400社で構成され、構成企業が複数の株式クラスを発行している場合は構成数が400を超えることもあります。
ACHC vs FN — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $821.5M | $1.1B |
| 純利益 | $-1.2B | $112.6M |
| 粗利率 | — | 12.2% |
| 営業利益率 | -142.4% | 10.1% |
| 純利益率 | -143.3% | 9.9% |
| 売上前年比 | 6.1% | 35.9% |
| 純利益前年比 | -3710.4% | 30.0% |
| EPS（希薄化後） | $-12.98 | $3.11 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $821.5M | $1.1B | ||
| Q3 25 | $851.6M | $978.1M | ||
| Q2 25 | $869.2M | $909.7M | ||
| Q1 25 | $770.5M | $871.8M | ||
| Q4 24 | $774.2M | $833.6M | ||
| Q3 24 | $815.6M | $804.2M | ||
| Q2 24 | $796.0M | $753.3M | ||
| Q1 24 | $768.1M | $731.5M |
| Q4 25 | $-1.2B | $112.6M | ||
| Q3 25 | $36.2M | $95.9M | ||
| Q2 25 | $30.1M | $87.2M | ||
| Q1 25 | $8.4M | $81.3M | ||
| Q4 24 | $32.6M | $86.6M | ||
| Q3 24 | $68.1M | $77.4M | ||
| Q2 24 | $78.5M | $81.1M | ||
| Q1 24 | $76.4M | $80.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | -142.4% | 10.1% | ||
| Q3 25 | 4.7% | 9.6% | ||
| Q2 25 | 5.8% | 9.8% | ||
| Q1 25 | 1.7% | 9.0% | ||
| Q4 24 | 4.9% | 9.5% | ||
| Q3 24 | 12.1% | 9.6% | ||
| Q2 24 | 13.4% | 9.7% | ||
| Q1 24 | 12.9% | 9.7% |
| Q4 25 | -143.3% | 9.9% | ||
| Q3 25 | 4.3% | 9.8% | ||
| Q2 25 | 3.5% | 9.6% | ||
| Q1 25 | 1.1% | 9.3% | ||
| Q4 24 | 4.2% | 10.4% | ||
| Q3 24 | 8.4% | 9.6% | ||
| Q2 24 | 9.9% | 10.8% | ||
| Q1 24 | 9.9% | 11.1% |
| Q4 25 | $-12.98 | $3.11 | ||
| Q3 25 | $0.40 | $2.66 | ||
| Q2 25 | $0.33 | $2.41 | ||
| Q1 25 | $0.09 | $2.25 | ||
| Q4 24 | $0.36 | $2.38 | ||
| Q3 24 | $0.74 | $2.13 | ||
| Q2 24 | $0.85 | $2.22 | ||
| Q1 24 | $0.83 | $2.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $133.2M | $960.8M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $1.9B | $2.2B |
| 総資産 | $5.5B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 1.28× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $133.2M | $960.8M | ||
| Q3 25 | $118.7M | $968.8M | ||
| Q2 25 | $131.4M | $934.2M | ||
| Q1 25 | $91.2M | $950.7M | ||
| Q4 24 | $76.3M | $934.6M | ||
| Q3 24 | $82.1M | $908.9M | ||
| Q2 24 | $77.2M | $858.6M | ||
| Q1 24 | $77.3M | $794.0M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | $2.0B | ||
| Q1 25 | $3.0B | $1.9B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | $1.7B | ||
| Q1 24 | $2.9B | $1.7B |
| Q4 25 | $5.5B | $3.3B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $2.8B | ||
| Q1 25 | $6.1B | $2.6B | ||
| Q4 24 | $6.0B | $2.5B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $5.7B | $2.3B | ||
| Q1 24 | $5.5B | $2.2B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-86.3M | $46.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $-179.5M | $-5.3M |
| FCFマージンFCF / 売上 | -21.8% | -0.5% |
| 設備投資強度設備投資 / 売上 | 11.3% | 4.6% |
| キャッシュ転換率営業CF / 純利益 | — | 0.41× |
| 直近12ヶ月FCF直近4四半期 | $-439.9M | $102.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-86.3M | $46.3M | ||
| Q3 25 | $73.2M | $102.6M | ||
| Q2 25 | $133.5M | $55.1M | ||
| Q1 25 | $11.5M | $74.2M | ||
| Q4 24 | $116.7M | $115.9M | ||
| Q3 24 | $163.1M | $83.2M | ||
| Q2 24 | $171.1M | $83.1M | ||
| Q1 24 | $-321.3M | $100.9M |
| Q4 25 | $-179.5M | $-5.3M | ||
| Q3 25 | $-63.0M | $57.3M | ||
| Q2 25 | $-34.2M | $4.7M | ||
| Q1 25 | $-163.2M | $45.7M | ||
| Q4 24 | $-86.8M | $94.0M | ||
| Q3 24 | $-27.1M | $62.9M | ||
| Q2 24 | $16.9M | $70.4M | ||
| Q1 24 | $-463.7M | $87.3M |
| Q4 25 | -21.8% | -0.5% | ||
| Q3 25 | -7.4% | 5.9% | ||
| Q2 25 | -3.9% | 0.5% | ||
| Q1 25 | -21.2% | 5.2% | ||
| Q4 24 | -11.2% | 11.3% | ||
| Q3 24 | -3.3% | 7.8% | ||
| Q2 24 | 2.1% | 9.3% | ||
| Q1 24 | -60.4% | 11.9% |
| Q4 25 | 11.3% | 4.6% | ||
| Q3 25 | 16.0% | 4.6% | ||
| Q2 25 | 19.3% | 5.5% | ||
| Q1 25 | 22.7% | 3.3% | ||
| Q4 24 | 26.3% | 2.6% | ||
| Q3 24 | 23.3% | 2.5% | ||
| Q2 24 | 19.4% | 1.7% | ||
| Q1 24 | 18.5% | 1.9% |
| Q4 25 | — | 0.41× | ||
| Q3 25 | 2.02× | 1.07× | ||
| Q2 25 | 4.43× | 0.63× | ||
| Q1 25 | 1.37× | 0.91× | ||
| Q4 24 | 3.58× | 1.34× | ||
| Q3 24 | 2.39× | 1.07× | ||
| Q2 24 | 2.18× | 1.02× | ||
| Q1 24 | -4.21× | 1.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
